Our results demonstrating that knockdown of CD109 in hBM-MSCs abrogates the inhibitory effects of hBM-MSC-CM on EMT, migration, invasion and spheroid formation in SCC cells, indicate that CD109 released from hBM-MSCs is essential for these anti-tumor effects. Here, CD109 is linked to neoplasm.